- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
PharmaResources (Shanghai)
Market Cap: CN¥5.9b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥32.80
7D
-4.1%
1Y
12.4%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥11.1b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
300725
CN¥47.74
7D
-3.6%
1Y
9.8%
AcrobiosystemsLtd
Market Cap: CN¥14.8b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥88.30
7D
3.0%
1Y
56.9%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.1b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥24.72
7D
-4.5%
1Y
-22.6%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.8b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.28
7D
-1.3%
1Y
-6.4%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.4b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥43.19
7D
5.2%
1Y
-23.4%